|
|
|
|
LEADER |
01000cam a2200265 4500 |
001 |
187242364 |
003 |
DE-627 |
005 |
20240418021628.0 |
007 |
tu |
008 |
950904s1995 gw ||||| 00| ||ger c |
015 |
|
|
|a 95,N34,0612
|2 dnb
|
015 |
|
|
|a 96,A02,0911
|2 dnb
|
016 |
7 |
|
|a 945024576
|2 DE-101
|
020 |
|
|
|a 3437116800
|c : DM 78.00 (kart.)
|9 3-437-11680-0
|
035 |
|
|
|a (DE-627)187242364
|
035 |
|
|
|a (DE-576)050782711
|
035 |
|
|
|a (DE-599)GBV187242364
|
035 |
|
|
|a (OCoLC)845038505
|
035 |
|
|
|a (OCoLC)35715598
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a ger
|a eng
|
044 |
|
|
|c XA-DE
|c XD-US
|
060 |
|
0 |
|a WG 106
|
084 |
|
|
|a 33
|2 sdnb
|
084 |
|
|
|a XI 4303
|2 rvk
|0 (DE-625)rvk/153005:12909
|
084 |
|
|
|a 44.38
|2 bkl
|
245 |
1 |
4 |
|a Die Gefäßwand als pharmakologischer Angriffspunkt
|b 5 Tabellen
|c hrsg. von Hans J. Dengler ... Unter Mitarb. von G. Bauriedel ...
|
263 |
|
|
|a kart. : DM 78.00
|
264 |
|
1 |
|a Stuttgart
|a Jena
|a New York
|b G. Fischer
|c 1995
|
300 |
|
|
|a 187 S.
|b Ill., graph. Darst.
|c 23 cm
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Beitr. teilw. dt., teilw. engl. - Literaturangaben
|
583 |
1 |
|
|a Archivierung prüfen
|c 20200919
|f DE-640
|z 3
|2 pdager
|
583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|x XA-DE-BW
|2 pdager
|5 DE-24
|
583 |
1 |
|
|a Archivierung prüfen
|c 20240324
|f DE-4165
|z 1
|2 pdager
|
650 |
|
2 |
|a Blood Vessels
|x physiopathology
|x congresses
|
650 |
|
2 |
|a Endothelium, Vascular
|x physiopathology
|x congresses
|
650 |
|
2 |
|a Renin-Angiotensin System
|x congresses
|
689 |
0 |
0 |
|D s
|0 (DE-588)4195860-3
|0 (DE-627)104382589
|0 (DE-576)210103914
|a Gefäßwand
|2 gnd
|
689 |
0 |
1 |
|D s
|0 (DE-588)4059964-4
|0 (DE-627)106141457
|0 (DE-576)209133139
|a Thrombozyt
|2 gnd
|
689 |
0 |
2 |
|D s
|0 (DE-588)4007275-7
|0 (DE-627)104589825
|0 (DE-576)208869484
|a Blutgerinnung
|2 gnd
|
689 |
0 |
3 |
|D s
|0 (DE-588)4064937-4
|0 (DE-627)104297778
|0 (DE-576)209155922
|a Wechselwirkung
|2 gnd
|
689 |
0 |
|
|5 DE-101
|
689 |
1 |
0 |
|D s
|0 (DE-588)4195860-3
|0 (DE-627)104382589
|0 (DE-576)210103914
|a Gefäßwand
|2 gnd
|
689 |
1 |
1 |
|D s
|0 (DE-588)4076066-2
|0 (DE-627)106083872
|0 (DE-576)209200707
|a Pharmakotherapie
|2 gnd
|
689 |
1 |
2 |
|D s
|0 (DE-588)4064937-4
|0 (DE-627)104297778
|0 (DE-576)209155922
|a Wechselwirkung
|2 gnd
|
689 |
1 |
|
|5 DE-101
|
700 |
1 |
|
|a Dengler, Hans J.
|e hrsg
|0 (DE-627)1236197232
|0 (DE-576)166197238
|4 edt
|
700 |
1 |
|
|a Bauriedel, Gerhard
|4 oth
|
856 |
4 |
2 |
|u http://www.gbv.de/dms/bs/toc/187242364.pdf
|m V:DE-601
|m B:DE-84
|q pdf/application
|x Verlag
|y Inhaltsverzeichnis
|3 Inhaltsverzeichnis
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a ISIL_DE-84
|
912 |
|
|
|a SYSFLAG_1
|
912 |
|
|
|a GBV_KXP
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a SSG-OPC-PHA
|
912 |
|
|
|a SSG-OPC-DE-84
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a ISIL_DE-18
|
912 |
|
|
|a GBV_ILN_22_i06404
|
912 |
|
|
|a GBV_ILN_24
|
912 |
|
|
|a ISIL_DE-8
|
912 |
|
|
|a GBV_ILN_31
|
912 |
|
|
|a ISIL_DE-27
|
912 |
|
|
|a GBV_ILN_62
|
912 |
|
|
|a ISIL_DE-28
|
912 |
|
|
|a GBV_ILN_65
|
912 |
|
|
|a ISIL_DE-3
|
912 |
|
|
|a GBV_ILN_65_a150
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a ISIL_DE-21
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a ISIL_DE-14
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a ISIL_DE-24
|
912 |
|
|
|a GBV_ILN_2018
|
912 |
|
|
|a ISIL_DE-31
|
935 |
|
|
|i Blocktest
|
936 |
r |
v |
|a XI 4303
|b Kompendien, Repetitorien, Leitfäden, Kurzdarstellungen, programmierter Unterricht
|k Medizin
|k Pharmakologie und Toxikologie
|k Spezielle Pharmakologie und Toxikologie
|k Kardiovaskuläres System: Herzmittel, Digitalisglykoside, Strophantine, Coffein, zentrale Analeptika
|k A. Formalschlüssel
|k Kompendien, Repetitorien, Leitfäden, Kurzdarstellungen, programmierter Unterricht
|0 (DE-627)1271626985
|0 (DE-625)rvk/153005:12909
|0 (DE-576)201626985
|
936 |
b |
k |
|a 44.38
|j Pharmakologie
|0 (DE-627)106409743
|
951 |
|
|
|a BO
|
980 |
|
|
|2 20
|1 01
|x 0084
|b 161258484
|c 00
|f --%%--
|d 2738-9636
|e --%%--
|j --%%--
|y k
|z 25-01-96
|
980 |
|
|
|2 22
|1 01
|x 0018
|b 221829148
|c 00
|f 18/64
|d WG 106 Med A 1995/540
|e u
|j --%%--
|c 03
|f --%%--
|d Med A 1995/540
|e --%%--
|j --%%--
|y zi06404
|z 09-12-96
|
980 |
|
|
|2 24
|1 01
|x 8/202
|b 176633235
|c 00
|f 29
|d MT 2103
|e u
|j --%%--
|h ma
|y zz1
|z 04-03-96
|
980 |
|
|
|2 31
|1 01
|x 0027
|b 219965781
|c 00
|f J 11
|d MED:PK:5000:Den::1995
|e d
|j --%%--
|c 09
|f --%%--
|d 96 NA 2276/1
|e --%%--
|j --%%--
|y n
|z 21-02-01
|
980 |
|
|
|2 62
|1 01
|x 0028
|b 181391929
|c 00
|f 28/BB4-H603
|d XI 4303 D392
|e g
|j --%%--
|c 09
|f --%%--
|d 96 A 21819
|e --%%--
|j --%%--
|y zbb4
|z 17-04-96
|
980 |
|
|
|2 65
|1 01
|x 3/150
|b 16787800X
|c 00
|f Ha 150
|d 44.85/1995:0410
|e u
|j --%%--
|y za150
|z 29-11-95
|
980 |
|
|
|2 2001
|1 01
|x DE-21
|b 3107410977
|c 00
|f --%%--
|d AR 95/180
|e --%%--
|j --%%--
|y l01
|z 14-03-96
|
980 |
|
|
|2 2006
|1 01
|x DE-14
|b 3107411051
|c 00
|f --%%--
|d --%%--
|e --%%--
|j --%%--
|k LSTO-K: 32
|y l01
|z 04-08-98
|
980 |
|
|
|2 2008
|1 01
|x DE-24
|b 3107411140
|c 00
|f --%%--
|d 45/18696
|e --%%--
|j --%%--
|k st 3a
|y l01
|z 25-03-96
|
980 |
|
|
|2 2018
|1 01
|x DE-31
|b 3107411221
|c 00
|f --%%--
|d 95 A 16795
|e --%%--
|j --%%--
|k 06.03.96/bi
|y l01
|z 06-03-96
|
982 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a Gefäßwand / Pharmakologie / Kongreß / Mainz <1993>
|
982 |
|
|
|2 65
|1 01
|x 3/150
|8 00
|a Angiologie; Pharmakotherapie
|
983 |
|
|
|2 24
|1 01
|x 8/202
|8 50
|0 (DE-627)058013792
|a mdk 147
|b Pharmakologie des kardiovaskulaeren Systems
|
983 |
|
|
|2 24
|1 01
|x 8/202
|8 51
|0 (DE-627)058020640
|a mdm 257
|b Blutgefaesssystem
|b Bau und Funktion
|
983 |
|
|
|2 31
|1 00
|x DE-27
|8 00
|a MED
|
983 |
|
|
|2 65
|1 01
|x 3/150
|8 00
|a 0502
|
983 |
|
|
|2 65
|1 01
|x 3/150
|8 01
|a 0602
|
984 |
|
|
|2 20
|1 01
|x 0084
|a 84$027389636
|x 00
|
984 |
|
|
|2 22
|1 01
|x 0018
|a 056018118
|x 00
|
984 |
|
|
|2 31
|1 01
|x 0027
|a 27$007174179
|
984 |
|
|
|2 62
|1 01
|x 0028
|a 28$009374973
|
984 |
|
|
|2 65
|1 01
|x 3/150
|a 3/150$00015334
|
985 |
|
|
|2 22
|1 01
|x 0018
|a 1995.1124
|
985 |
|
|
|2 31
|1 01
|x 0027
|a D96/G/385
|
995 |
|
|
|2 24
|1 01
|x 8/202
|a ma
|